Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 272

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Direct antiviral agent treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers fibrosis‐4 score and aspartate aminotransferase‐platelet ratio index

Bachofner, Jacqueline A., Valli, Piero V., Kröger, Arne, Bergamin, Irina, Künzler, Patrizia, Baserga, Adriana, Braun, Dominique, Seifert, Burkhardt, Moncsek, Anja, Fehr, Jan, Semela, David, Magenta, Lorenzo, Müllhaupt, Beat, Terziroli Beretta‐Piccoli, Benedetta, Mertens, Joachim C. · 2017 · Liver International

Abstract

Background: Novel direct antiviral agents (DAA) targeting hepatitis C virus (HCV) have revolutionized the treatment of chronic hepatitis C infection (CHC). Rates of sustained virological response (SVR) to treatment have drastically improved since introduction of DAA. Transient Elastography (TE) is an ultrasound based, non‐invasive technique to assess liver stiffness (LS). We examined the changes in TE values and fibrosis scores FIB‐4 and APRI after DAA treatment of CHC. Methods: 549 patients who received a DAA based treatment for CHC were screened and 392 were included. TE values recorded prior to therapy and within 18 months after therapy were evaluated. In addition, FIB‐4 and APRI scores were calculated and histopathological results were recorded if available. Results: Median TE prior to DAA treatment was 12.65 kP a (IQR 9.45‐19.2 kPa) and decreased to 8.55 kPa (IQR 5.93‐15.25) post‐treatment. This finding is statistically significant (P<.001) and equals a TE regression of 32.4% after DAA treatment. Median FIB‐4 and APRI values significantly decreased from 2.54 (IQR 1.65‐4.43) and 1.10 (IQR 0.65‐2.43) to 1.80 (IQR 1.23‐2.84, P<.001) and 0.43 (IQR 0.3‐0.79, P<.001) respectively. Conclusion: Patients with SVR after DAA therapy showed significant regression of TE values. Rapid decrease in TE was in concordance with regression of validated fibrosis scores FIB‐4 and APRI. It remains to be examined whether this indicates a true regression of fibrosis or merely resolution of chronic liver inflammation with subsequent improvement of TE values and laboratory parameters.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/liv.13256

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 21 references

Cited by

See all 272

Metadata

Authors
Bachofner, J. A., Valli, P. V., Kröger, A., Bergamin, I., Künzler, P., Baserga, A., Braun, D., Seifert, B., Moncsek, A., Fehr, J., Semela, D., Magenta, L., Müllhaupt, B., Terziroli Beretta‐Piccoli, B., & Mertens, J. C.
Venue
Liver International
Publisher
Wiley
Published
2016-11-03
Volume
37
Issue
3
Pages
369-376
ISSN
  • 0106-9543 (ISSN-L)
  • 1478-3223
  • 1478-3231
OpenAlex
W2524249329
Cited by
272
References
21
FWCI
18.01
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Direct antiviral agent treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers fibrosis‐4 score and aspartate aminotransferase‐platelet ratio index. https://app.cochat.ai/papers/10.1111/liv.13256
The paper
Bachofner, J. A., Valli, P. V., Kröger, A., Bergamin, I., Künzler, P., Baserga, A., Braun, D., Seifert, B., Moncsek, A., Fehr, J., Semela, D., Magenta, L., Müllhaupt, B., Terziroli Beretta‐Piccoli, B., & Mertens, J. C. (2017). Direct antiviral agent treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers fibrosis‐4 score and aspartate aminotransferase‐platelet ratio index. Liver International. https://doi.org/10.1111/liv.13256

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.